Brian Piekos - Chief Financial Officer at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
KALV on Nasdaq
All Insider Reports
All Insider Reports

Brian Piekos - trading volume in the past year for KalVista Pharmaceuticals, Inc.

Holdings reported by Brian Piekos for KalVista Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 60,000 $785,936 $9.82 21 Feb 2026 Direct Common Stock
Common Stock 13,762 $214,230 $15.57 23 Feb 2026 Direct

Transactions reported by Brian Piekos for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.